SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-19-005114
Filing Date
2019-04-10
Accepted
2019-04-10 16:05:15
Documents
3
Period of Report
2019-04-10
Effectiveness Date
2019-04-10

Document Format Files

Seq Description Document Type Size
1 def14a.htm DEF 14A 377744
2 proxy_001.jpg GRAPHIC 159345
3 proxy_002.jpg GRAPHIC 145774
  Complete submission text file 0001493152-19-005114.txt   799278
Mailing Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37348 | Film No.: 19741729
SIC: 2834 Pharmaceutical Preparations